Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,098,687
+$89,631 QoQ
Shares Held
12,201
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,989
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Obermeyer Wealth Partners holds $14,931,348 across 9 Drug Manufacturers - General names. JNJ ranks #1 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
12,201 | $3,098,687 | |
| 2 | ABBV |
AbbVie Inc.
|
10,832 | $2,725,764 | |
| 3 | AZN |
Astrazeneca PLC
|
11,635 | $2,206,228 | |
| 4 | LLY |
ELI LILLY & Co
|
1,757 | $2,107,398 | |
| 5 | AMGN |
Amgen Inc
|
3,986 | $1,443,410 | |
| 6 | PFE |
Pfizer Inc
|
49,336 | $1,188,010 | |
| 7 | MRK |
Merck & Co., Inc.
|
8,359 | $1,074,131 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,532 | $722,093 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,098,687 | 12,201 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,009,056 | 12,310 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,604,258 | 12,584 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,382,090 | 12,847 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,414,672 | 15,808 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $22,237,651 | 134,091 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $20,228,867 | 139,876 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,156,987 | 149,062 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $22,920,226 | 156,816 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $26,154,818 | 165,338 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $27,143,919 | 173,178 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $28,304,759 | 181,732 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $30,267,814 | 182,865 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $28,962,525 | 186,855 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $34,309,139 | 194,221 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $32,123,927 | 196,645 | Shares | Sole | 2022-12-09 | |
| 2022-06-30 | $34,528,712 | 194,517 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,214,597 | 18,138 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,092,774 | 18,079 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $3,720,798 | 23,039 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $3,589,190 | 21,787 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $3,565,901 | 21,697 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,698,280 | 17,145 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,597,509 | 17,447 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $2,473,541 | 17,589 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,213,474 | 16,880 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||